Administration of a competitive NMDA antagonist MDL-100,453 reduces infarct size after permanent middle cerebral artery occlusion in rat.

Jiang, N

Administration of a competitive NMDA antagonist MDL-100,453 reduces infarct size after permanent middle cerebral artery occlusion in rat. [electronic resource] - Journal of the neurological sciences Jun 1996 - 36-41 p. digital

Publication Type: Journal Article

0022-510X

10.1016/0022-510x(95)00352-3 doi


Animals
Arterial Occlusive Diseases--drug therapy
Brain Ischemia--drug therapy
Cerebral Arteries
Cerebral Infarction--drug therapy
Dose-Response Relationship, Drug
Drug Administration Schedule
Excitatory Amino Acid Antagonists--pharmacology
Infusions, Intravenous
Male
Rats
Rats, Sprague-Dawley
Receptors, N-Methyl-D-Aspartate--antagonists & inhibitors
Valine--analogs & derivatives